GLS

Gelesis Holdings, Inc. GLS

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode GLS AMTI OBSV KRRO HURA SCPX AXLA SQZB CYCC NTBL
6M -43.56 % -15.43 % -44.97 % 126.11 % -46.43 % 0.00 % 0.00 % -17.86 % -88.90 % -74.44 %
YTD -69.50 % 0.00 % -35.16 % -1.00 % -45.26 % -99.28 % 0.00 % -23.33 % -92.85 % -86.53 %
1Y -96.44 % -56.89 % -92.78 % -40.09 % -55.80 % -99.68 % 0.00 % 0.00 % -96.68 % -93.44 %
3Y -98.39 % -99.34 % -95.24 % -50.48 % -56.31 % -99.98 % -89.71 % -99.17 % -99.86 % -99.66 %
5Y -98.39 % -98.54 % -99.32 % -96.30 % -97.02 % -100.00 % -96.03 % -99.83 % -99.95 % -99.40 %
10Y -98.39 % -98.54 % -99.22 % -94.07 % -99.86 % -100.00 % -98.67 % -99.83 % -100.00 % -99.88 %
From the beginning -98.39 % -98.54 % -99.22 % -94.07 % -99.93 % -100.00 % -98.67 % -99.83 % -100.00 % -99.88 %

Dividend

Cyclacel Pharmaceuticals, Inc.